tiprankstipranks
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
US Market

XORTX Therapeutics Inc (XRTX) Income Statement

Compare
56 Followers

XORTX Therapeutics Inc Income Statement

Last quarter (Q3 2024), XORTX Therapeutics Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, XORTX Therapeutics Inc's net income was $-587.01K. See XORTX Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
-$ -75.27K$ -17.88K$ -20.44K$ -19.90K
Operating Expenses
$ 4.81M$ 9.86M$ 2.86M$ 1.30M$ 565.97K
Depreciation and Amortization
$ 188.54K$ 75.27K$ 17.88K$ 20.44K$ 19.90K
EBITDA
-$ -9.41M$ -1.63M$ -1.25M$ -572.47K
Operating Income
---$ -1.30M$ -565.97K
Other Income/Expenses
$ 1.95M$ 2.95M$ 1.25M$ -202.36K$ -63.61K
Pretax Income
---$ -1.28M$ -629.58K
Net Income
---$ -1.28M$ -629.58K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.44$ -4.72$ -1.19$ -1.73$ -1.06
Diluted EPS
$ -1.44$ -4.72$ -1.19$ -1.73$ -1.06
Weighted Average Shares Outstanding
1.98M 1.48M 1.09M 740.45K 595.49K
Weighted Average Shares Outstanding (Diluted)
1.98M 1.48M 1.09M 740.45K 595.49K
Currency in USD

XORTX Therapeutics Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis